Theta Research
  • Home
  • Graph
  • CompaniesPro
  • Pulse
  • Shipped
  • Engine

For serious investors who think in systems.

AboutAbout
ToolsOption LabDashboard
FeedbackRoadmap
© 2026 theta.md
← Back to Events
COMPLETEDTier 2earnings-single

Applied Materials Q2 FY2026 Earnings — Share Dynamics Test + HBM Equipment Doubling Validation

2026-05-15 → 2026-05-15·10 companies·10 predictions·Brier: 0.217
?AMATdirect?LRCXcompetitive?TSMsupply-chain?KLACcompetitive?MUsupply-chain?ASMLcompetitive?SKHynixsupply-chain?INTCsupply-chain—NVDAsupply-chain?AMKRsupply-chain

Scenario Comparison

Bull CaseS1
20%

Q2 revenue exceeds $8.0B (5%+ above $7.65B guide), non-GAAP EPS >$2.80. Q3 FY2026 guided at $8.2B+. Management raises FY2026 outlook, explicitly reaffirms >20% CY2026 growth with upward bias. HBM equipment run-rate commentary implies >$2.5B annualized.

↑ 7↓ 07 companies
+AMATstrong
+LRCXmoderate
+TSMmoderate
+KLACmoderate
+3 more
Base CaseS2
35%

Q2 revenue $7.7-8.0B (meets/slightly beats consensus $7.69B), non-GAAP EPS $2.65-2.80. Q3 guided at $7.9-8.1B. Reaffirms >20% CY2026 growth without raising outlook. Gross margin sustains ~49%. Standard HBM/packaging commentary.

↑ 0↓ 04 companies
~AMATmild
~LRCXmild
~TSMmild
~MUmild
Bear CaseS6
5%

Q2 revenue <$7.4B, EPS <$2.50. Q3 guide below $7.5B. Management withdraws or significantly qualifies >20% growth. China headwind larger than $710M. Two or more top-5 customers signaling capex moderation. WFE cycle peak declared by management or implied by order patterns.

↑ 0↓ 77 companies
−AMATstrong
−LRCXstrong
−KLACstrong
−ASMLmoderate
+3 more

All Scenarios

6

Positioning Suggestions

→ Stock at $431 is ABOVE thesis base target of $403 — current price requires a guidance raise (Scenario 1) to be justified. If holding, tighten stop-loss to $400 (original base level). A beat-and-maintain (Scenario 2) is already priced in.

→ If Q2 revenue >$8B AND Q3 guide >$8.2B: thesis re-rate needed. Bull target $476 becomes new base. Consider adding to position on confirmation.

→ If guidance misses (Scenario 3): expect -8-12% correction. Consider trimming 20% of position pre-earnings if conviction has declined. Re-entry target at $380-400 if base thesis still intact.

→ Pair trade consideration: if Castellano share-loss thesis is confirmed (Scenario 4), go long LRCX / short AMAT on competitive dynamics rotation within the WFE sector.

→ LRCX reports May 21 (one week after AMAT) — AMAT's results set the tone for the entire WFE sector. Watch LRCX stock reaction to AMAT's call as a cross-read on share dynamics.

Predictions

10
✗

AMAT Q2 FY2026 revenue exceeds $8.0B (vs $7.65B guidance midpoint), validating >20% CY2026 growth trajectory

25%P1

If confirmed → thesis re-rate needed, bull target $476 becomes achievable. Consider adding on pullback.

✓

AMAT Q2 FY2026 non-GAAP EPS exceeds consensus of $2.68, continuing the 4-quarter beat streak

60%P2

If confirmed → supports margin expansion narrative. Watch magnitude — beat by >$0.10 is meaningful, <$0.05 is noise.

✓

Q3 FY2026 guidance revenue midpoint exceeds $8.0B, implying sequential acceleration and H2 strength

30%P3

If confirmed → base case revision upward needed, current $431 price justified. If Q3 guide <$7.8B → trim 20%.

✓

Management explicitly reaffirms >20% CY2026 semiconductor equipment growth in prepared remarks or Q&A

80%P4

If NOT reaffirmed (withdrawn or heavily qualified) → immediate bear signal, expect -8%+ selloff.

✗

DRAM as percentage of Semi Systems revenue sustains at or above 33% in Q2 FY2026

70%P5

If confirmed at 33%+ for 2nd consecutive quarter → strengthens secular content-per-wafer thesis. 3rd quarter at 33%+ = bull trigger confirmed.

✓

Gross margin sustains at or above 49.0% in Q2 FY2026 (matching Q1 level)

55%P6

If confirmed → favorable mix shift toward AI tools is durable. If drops below 48.5% → bear signal on mix deterioration.

✗

China revenue declines to below 23% of total revenue in Q2 FY2026 (was ~25% in Q1)

45%P7

If confirmed → export control + domestic mandate headwind accelerating. Watch for commentary on ICAPS tool restrictions.

✗

Management provides a specific advanced packaging revenue figure for the first time (any dollar amount disclosed)

15%P8

If disclosed at >$3B run-rate → packaging thesis crystallized, significant positive catalyst. Rare but high-impact.

✓

AMAT stock closes above $445 within 2 trading days of earnings (May 16-19)

30%P9

Requires strong beat + raise. At $431 pre-earnings, +3.3% post-earnings move implies Scenario 1. Below $420 implies Scenario 3+.

✗

Management directly addresses or pushes back on the Castellano market share analysis during the earnings call

10%P10

Unlikely — companies rarely address independent analyst critiques directly. If they do, the pushback quality matters more than the fact of response.

Key Questions

  1. Does Q2 revenue exceed $8B, validating the >20% CY2026 semi equipment growth claim — or is the growth rate decelerating?
  2. What does Q3 FY2026 guidance imply for H2 momentum — sequential acceleration or deceleration from Q2?
  3. Does management address the Castellano share-loss analysis? If segment data is disclosed, does deposition/CMP share show erosion vs LRCX/KLAC?
  4. Is DRAM as % of Semi Systems sustaining above 33% — confirming secular content-per-wafer inflection, or is HBM pull-in normalizing?
  5. Does gross margin hold at 49%+ — confirming favorable AI tool mix — or is ICAPS drag / China mix shift compressing margins?
  6. Any update on HBM equipment run-rate — does the $3B doubling target have a specific timeline (FY2027 or FY2028)?
  7. Is China revenue declining below 23%? Any commentary on the 50% domestic equipment mandate impact on ICAPS tools?
  8. Besi acquisition status — is AMAT or LRCX closer to a deal, and what does it signal for advanced packaging competitive dynamics?

Monitoring Checklist

0/12 checked

Post-Event Results

Brier Score0.217
correct5/10
Trade Actions7

Actual Outcomes

  • • Q2 FY2026 reported after close on May 14, 2026: revenue $7.91B (+11% YoY) vs $7.69B consensus and $7.65B guide midpoint — a beat but below the $8.0B headline threshold the bull case required.
  • • Non-GAAP EPS $2.86 vs $2.68 consensus (beat by $0.18, +6.7%); GAAP EPS $3.51 (+33% YoY).
  • • Gross margin: GAAP 49.9%, non-GAAP 50.0% — record level (highest in 25 years), confirming favorable AI-tool mix shift.
  • • Semiconductor Systems segment revenue $5.97B (+16% QoQ).
  • • DRAM revenue $1.7B (+18% YoY) but only ~28.5% of Semi Systems vs 34% in Q1 — DRAM mix DECLINED as foundry/logic + advanced packaging segments grew faster.
  • • China revenue 24% of Semi Systems + AGS (down from 25% in Q1 but above the 23% bear threshold); management expects ICAPS flat to slightly higher CY2026.
  • • Q3 FY2026 guidance: revenue $8.95B ± $0.50B, non-GAAP EPS $3.36 ± $0.20 — massive sequential acceleration, ~23% YoY at midpoint.
  • • Management RAISED CY2026 semi equipment growth outlook from >20% to >30% — the dominant signal of the quarter.
  • • Long-term collaboration agreement with SK Hynix announced for next-gen DRAM/HBM development.
  • • Advanced packaging forecast >50% growth in CY2026; leading-edge foundry logic + DRAM + advanced packaging projected to drive >80% of WFE growth in 2026 and 2027.
  • • No specific advanced packaging dollar revenue figure disclosed — guidance commentary only.
  • • AMAT stock hit all-time high $448.45 intraday May 14; +4.12% post-earnings on May 15 (initial spike, later faced sector pressure from Samsung labor concerns and TSMC stake sale).
  • • Analyst PT raises May 15: Cantor $575 (from $550), Deutsche Bank $550 (from $450), B. Riley $550 (from $530), BofA $540 (from $465), Stifel $530 (from $500), TD Cowen $525 (from $450), RBC $520 (from $500), UBS $515 (from $480), Morgan Stanley $502 (from $454, BUT downgraded to Equal-weight on valuation and China exposure).
  • • Earnings call language indirectly acknowledged process control market share decline (partial confirmation of Castellano analysis) but did NOT directly address the analyst by name. Management framed AMAT as 'clear number 1' in leading-edge logic and DRAM, leaving inspection/process control as the one segment where share loss to KLAC is conceded.
  • • Peer reactions on May 14 (pre-AMAT-earnings close): LRCX +1.47%, KLAC ~flat, ASML -0.96% to -2.26%. Specific 5/15 closes for MU/SKHynix/TSM not captured in this review.

Market Reaction

AMAT+4.1%LRCX+1.5%KLAC+0.0%ASML-1.6%

Thesis Updates Needed

AMAT·Bull scenario (Scenario 1) actualized: beat + raise + CY2026 growth raised from >20% to >30% + record 50.0% non-GAAP GM + Q3 guide $8.95B blowout. Bull target $476 likely too low given new CY26 growth rate and 50%+ GM trajectory. Risks: process control share loss to KLAC acknowledged (partial Castellano vindication); DRAM % of Semi Systems fell to 28.5% from 34% as foundry/logic grew faster — secular DRAM-content thesis intact in absolute terms (+18% YoY) but mix shifted. China 24% still above the 23% bear threshold.
scenarioAnalysis.scenariosrisksmonitoring.catalystWatch
MU·AMAT DRAM equipment +18% YoY at record Semi Systems revenue confirms memory cycle intact. HBM equipment doubling target reaffirmed. AMAT–SK Hynix LT collaboration agreement re-anchors HBM/next-gen DRAM roadmap — MU is the read-across beneficiary. Memory capex catalyst confirmed, not normalizing.
monitoring.catalystWatchthesis
SKHynix·AMAT long-term collaboration agreement on next-gen DRAM/HBM is a direct partnership disclosure — anchors SK Hynix Y1 mega-fab tooling roadmap and validates HBM4 capacity buildout timeline. Bull catalyst confirmed at the supplier level.
thesismonitoring.catalystWatch
KLAC·AMAT earnings call indirectly acknowledged process control share decline — KLAC is the explicit beneficiary in inspection/metrology. Validates KLAC's premium multiple and monopolistic moat. Standalone long signal, not just a sector beta play.
thesisrisks
AMKR·Advanced packaging forecast >50% growth in CY2026 from AMAT — direct read-across to OSAT capacity needs. Watch for AMKR's own guidance refresh for confirmation. Bull catalyst.
monitoring.catalystWatchthesis
LRCX·Pair-trade thesis (long LRCX / short AMAT on Castellano share-loss) is now LOWER conviction: AMAT did not concede broad share loss, only process control (which goes to KLAC, not LRCX). WFE upcycle confirmed at >30% CY2026 — rising tide remains the dominant LRCX driver. Drop the pair trade; LRCX remains standalone long via WFE cycle.
risksscenarioAnalysis.triggerConditions
TSM·Record AMAT equipment demand at $7.91B confirms TSMC/Samsung/Intel capacity expansion on schedule. Advanced packaging tool orders validate CoWoS-L buildout. Capex demand signal positive.
monitoring.catalystWatch

Trade Recommendations

→ AMAT: Beat-and-raise Scenario 1 actualized. Bull target $476 within reach but stock already at ATH $448.45 — DO NOT chase. Add only on Samsung-labor / TSMC-stake-sale sector dips back to $410-420 zone. Original positioning ('If beat+raise: consider adding on pullback') still valid, but discipline on entry.

→ AMAT: Watch Morgan Stanley Equal-weight downgrade as the counter-signal — valuation + China exposure are real medium-term overhangs even at >30% CY26 growth. If stock holds >$460 on weak macro, position size becomes the risk.

→ MU / SKHynix: HBM equipment doubling validated and AMAT–SKHynix LT agreement confirms memory cycle anchor. Long memory bias intact. No add/trim trigger from this event alone.

→ KLAC: Standalone long signal — AMAT process control share concession is durable, not cyclical. Consider initiating or sizing up if price weakness emerges from sector sentiment.

→ AMKR: Advanced packaging +50% CY2026 forecast = bull signal. Watch AMKR's own next guidance for confirmation before adding.

→ LRCX: Drop pair-trade (long LRCX / short AMAT) — AMAT didn't admit broad share loss. LRCX remains standalone long via WFE upcycle.

→ Cross-sector: Equipment sector at >30% CY2026 growth + record AMAT margin = WFE cycle peak NOT here yet. Bear case (Scenario 6, p=0.05) decisively rejected for this earnings cycle.